Wiendl H, Spelman T, Butzkueven H, Kappos L, et al. Real-world disability improvement in patients with relapsing-remitting multiple
sclerosis treated with natalizumab in the Tysabri Observational Program. Mult Scler 2020 Jun 24:1352458520926869. doi: 10.1177/1352458520926869.
PMID: 32579430